Bipolar Disorder in Pregnancy and the Postpartum Period: Predictors of Morbidity
NCT ID: NCT00580268
Last Updated: 2014-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
118 participants
OBSERVATIONAL
2005-08-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bipolar Disorder (BPD) in Pregnancy: Predictors of Morbidity
NCT00864370
Identifying Predictors of Bipolar Disorder Relapse During Pregnancy and the Postpartum Period
NCT00720395
Antimanic Drug Use in Pregnancy
NCT00585702
A Study of Pregnant and Postpartum Women With and Without Mood Disorders
NCT03615794
Adjunctive Psychotherapy for Perinatal Bipolar Disorder
NCT02402738
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
H
Pregnant women with bipolar disorder
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. euthymic at the time of conception;
3. able to give informed consent and comply with study procedures;
4. have a treating psychiatrist, physician or mental health clinician. Gravid women between the ages of 18 and 45
Exclusion Criteria
2. active substance use disorder with 6 months prior to enrollment, or
3. positive urine drug screen at enrollment.
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Viguera, Adele
MD, Center for Women's Mental Health
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adele C Viguera, MD
Role: PRINCIPAL_INVESTIGATOR
MGH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emory University
Atlanta, Georgia, United States
Massachusetts Geral Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
MGH Center for Women's Mental Health
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2005P001167
Identifier Type: -
Identifier Source: org_study_id
NCT00320645
Identifier Type: -
Identifier Source: nct_alias
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.